Articles published by GlobeNewswire
TBLA Investors Have Opportunity to Lead Taboola.com Ltd. Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
TBLA
GDDY Investors Have Opportunity to Lead GoDaddy Inc. Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
GDDY
HDB Investors Have Opportunity to Lead HDFC Bank Limited Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
HDB
Bonnie & Clyde Shotgun Sells For $1 Million, Sets World Record
August 25, 2026
Via GlobeNewswire
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
REPL
Via GlobeNewswire
Tickers
RLNDF
From Allsteel
Via GlobeNewswire
Tickers
HNI
Anteriad Named a Notable Vendor in New B2B Intent Data Report
August 25, 2026
From Anteriad
Via GlobeNewswire
DVLT Investors Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
DVLT
DNOW Investors Have Opportunity to Lead DNOW Inc. Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
DNOW
BZAI Investors Have Opportunity to Lead Blaize Holdings, Inc. Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
BZAI
PCCA Partners with Tabz™ to Bring Its Unified Commerce Platform to Compounding Pharmacies
August 25, 2026
From PCCA
Via GlobeNewswire
WSE Investors Have Opportunity to Lead Wise Group plc Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
WSE
PNR Investors Have Opportunity to Lead Pentair plc Securities Fraud Lawsuit with SBS Law
August 25, 2026
Via GlobeNewswire
Tickers
PNR
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.


